Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment

Cancer Science

Volumn 101, Issue 4, 2010, Pages 1014-1023

  Tafani, Marco ^a   Russo, Andrea ^b   Di Vito, Maura ^c   Sale, Patrizio ^a   Pellegrini, Laura ^c   Schito, Luana ^c   Gentileschi, Stefano ^d   Bracaglia, Roberto ^d   Marandino, Ferdinando ^b   Garaci, Enrico ^e   Russo, Matteo A ^a,c  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR ALPHA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; PARTHENOLIDE; PENTRAXIN 3; PROSTAGLANDIN SYNTHASE; PURINERGIC P2X7 RECEPTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; HIF1A PROTEIN, HUMAN;

ARTICLE; BREAST CARCINOMA; CANCER INVASION; CARCINOMA CELL; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNE RESPONSE GENE; INFLAMMATORY INFILTRATE; INVASIVE CARCINOMA; LASER MICRODISSECTION; MESSENGER RNA SYNTHESIS; MORPHOLOGICAL ADAPTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; UPREGULATION; WESTERN BLOTTING; AGED; BREAST TUMOR; CELL HYPOXIA; DRUG ANTAGONISM; FEMALE; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; TUMOR CELL LINE;

AGED; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; MIDDLE AGED; NEOPLASM INVASIVENESS; NF-KAPPA B; UP-REGULATION;

EID: 77957274653     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01493.x     Document Type: Article

References (41)

1. Rius J, Guma M, Schachtrup C et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008; 453: 807-11.
2. Ravenna L, Sale P, Di Vito M et al. Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma. Prostate 2009; 69: 1245-55.
3. Chen CD, Sawyers CL. NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. Mol Cell Biol 2002; 22: 2862-70.
4. Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301-10.
5. Pikarsky E, Porat RM, Stein I et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 461-6.
6. Richmond A. Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol 2002; 2: 664-74.
7. Irwin DC, McCord JM, Nozik-Grayck E et al. A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leak. Free Radic Biol Med 2009; 47: 55-61.
8. Song IS, Wang AG, Yoon SY et al. Regulation of glucose metabolism-related genes and VEGF by HIF-1alpha and HIF-1beta, but not HIF-2alpha, in gastric cancer. Exp Mol Med 2009; 41: 51-8.
9. Pichiule P, Chavez JC, Schmidt AM, Vannucci SJ. Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia. J Biol Chem 2007; 282: 36330-40.
10. Walmsley SR, Print C, Farahi N et al. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med 2005; 201: 105-15.
11. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8: 279-89.
12. Baud V, Karin M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 2009; 8: 33-40.
13. Fulton AM. The chemokine receptors CXCR4 and CXCR3 in cancer. Curr Oncol Rep 2009; 11: 125-31.
14. Chu CY, Cha ST, Lin WC et al. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway. Carcinogenesis 2009; 30: 205-13.
15. Bos PD, Zhang XH, Nadal C et al. Genes that mediate breast cancer metastasis to the brain. Nature 2009; 459: 1005-9.
16. Hussain SP, He P, Subleski J et al. Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res 2008; 68: 7130-6.
17. Rocconi RP, Kirby TO, Seitz RS et al. Lipoxygenase pathway receptor expression in ovarian cancer. Reprod Sci 2008; 15: 321-6.
18. Deban L, Bottazzi B, Garlanda C, de la Torre YM, Mantovani A. Pentraxins: multifunctional proteins at the interface of innate immunity and inflammation. Biofactors 2009; 35: 138-45.
19. Souza DG, Amaral FA, Fagundes CT et al. The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice. Am J Pathol 2009; 174: 1309-18.
20. Crabtree M, Pileggi R, Bhattacharyya I et al. RAGE mRNA expression and its correlation with nuclear factor kappa beta mRNA expression in inflamed human periradicular tissues. J Endod 2008; 34: 689-92.
21. Tateno T, Ueno S, Hiwatashi K et al. Expression of receptor for advanced glycation end products (RAGE) is related to prognosis in patients with esophageal squamous cell carcinoma. Ann Surg Oncol 2009; 16: 440-6.
22. Tafani M, Schito L, Anwar T et al. Induction of autophagic cell death by a novel molecule is increased by hypoxia. Autophagy 2008; 4: 1042-53.
23. Müller A, Homey B, Soto H et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-6.
24. Cabioglu N, Summy J, Miller C et al. CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res 2005; 65: 6493-7.
25. Semenza GL. Hypoxia-inducible factor 1 and cancer pathogenesis. IUBMB Life 2008; 60: 591-7.
26. Chen LF, Greene WC. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 2004; 5: 392-401.
27. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 2000; 275: 25781-90.
28. Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci 2007; 28: 465-72.
29. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996; 87: 13-20.
30. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcrip-tion factors in the immune system. Annu Rev Immunol 2009; 27: 693-733.
31. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-32.
32. Kabe Y, Ando K, Hirao S, Yoshida M, Handa H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 2005; 7: 395-403.
33. Hwang KY, Oh YT, Yoon H et al. Baicalein suppresses hypoxia-induced HIF-1alpha protein accumulation and activation through inhibition of reactive oxygen species and PI 3-kinase/Akt pathway in BV2 murine microglial cells. Neurosci Lett 2008; 444: 264-9.
34. Sonveaux P, Végran F, Schroeder T et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008; 118: 3930-42.
35. Zou GM, Karikari C, Kabe Y, Handa H, Anders RA, Maitra A. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis. J Cell Physiol 2009; 219: 209-18.
36. Tajima M, Kurashima Y, Sugiyama K, Ogura T, Sakagami H. The redox state of glutathione regulates the hypoxic induction of HIF-1. Eur J Pharmacol 2009; 606: 45-9.
37. de Visser KE, Coussens LM. The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol 2006; 13: 118-37.
38. Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res 2008; 659: 15-30.
39. Goswami B, Rajappa M, Sharma M, Sharma A. Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies. Int J Gynecol Cancer 2008; 18: 591-9.
40. Quante M, Wang TC. Inflammation and stem cells in gastrointestinal carcinogenesis. Physiology (Bethesda) 2008; 23: 350-9.
41. Herfs M, Hubert P, Delvenne P. Epithelial metaplasia: adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation? Trends Mol Med 2009; 15: 245-53.